
https://www.science.org/content/blog-post/singularity-postponed
# The Singularity, Postponed (October 2011)

## 1. SUMMARY  
The author critiques two popular “accelerating‑returns” narratives that were circulating in the early 2010s.  

* First, the idea championed by Ray Kurzweil that a technological **Singularity**—a point at which machine intelligence surpasses human intelligence and triggers runaway progress—was imminent.  
* Second, the claim (often echoed by futurists and venture capitalists) that if we could produce a new generation of micro‑chips within five years, we would be able to cure cancer within ten.  

Citing a 2011 essay by Paul Allen in *MIT Technology Review*, the piece argues that the brain’s extraordinary structural complexity—shaped by millions of years of evolution and continually rewired by experience—poses a “complexity brake” far more limiting than any exponential hardware trend. The author concludes that, for the foreseeable future, scientific breakthroughs will be governed by new theoretical insights rather than raw increases in transistor counts, and that the singularity is therefore postponed.

---

## 2. HISTORY  

### AI and the “Law of Accelerating Returns”  
* **Deep learning breakthrough (2012‑2015).** Convolutional neural networks (e.g., AlexNet, 2012) and later transformer architectures (2017) produced dramatic performance gains in vision, language, and game‑playing. These advances were driven largely by larger datasets and GPUs, not by a fundamental change in hardware scaling law.  
* **Large language models (2020‑2024).** OpenAI’s GPT‑3 (2020), GPT‑4 (2023), and subsequent multimodal models demonstrated human‑level language generation and reasoning on many benchmarks, but they remain narrow tools lacking general agency. Their capabilities have spurred massive investment, yet no consensus exists that they constitute a “superintelligence” or that a singularity has arrived.  
* **Neuromorphic and brain‑inspired chips.** Projects such as IBM’s TrueNorth, Intel’s Loihi, and later research on memristive crossbars have produced specialized hardware for spiking neural networks, but adoption remains limited to niche research and low‑power edge devices. No commercial product has yet matched the flexibility of conventional GPUs for mainstream AI workloads.  

Overall, AI has progressed far faster than many experts anticipated in 2011, but the trajectory has been **incremental** rather than a sudden “break‑through” that would trigger a singularity. The field continues to be constrained by data availability, compute cost, and algorithmic understanding.

### Biotechnology, Cancer, and the “Cure in Ten Years” Claim  
* **CRISPR‑Cas9 (2012 discovery, 2015‑2020 clinical pipeline).** The gene‑editing platform rapidly entered pre‑clinical and early‑phase trials for sickle‑cell disease, β‑thalassemia, and certain cancers. By 2023, the first CRISPR‑based therapy (ex vivo edited autologous T‑cells) received FDA approval for a rare blood disorder, not for solid‑tumor cancer.  
* **AI‑driven drug discovery.** Companies such as Insilico Medicine, Exscientia, and BenevolentAI have used deep learning to design novel molecules. Some candidates have entered Phase I/II trials, but none have yet produced a blockbuster oncology drug.  
* **Cancer mortality trends.** From 2011 to 2025, age‑adjusted cancer death rates in the U.S. fell by roughly 30 % (American Cancer Society). Improvements stem from earlier detection, immunotherapy (e.g., checkpoint inhibitors approved 2014‑2020), and targeted therapies—not from a single “cure” enabled by faster chips.  

Thus, the optimistic timeline of curing cancer within a decade of a new chip generation has **not materialized**. Progress has been steady but fragmented across many modalities.

### Policy and Industry Impact  
* **Funding for brain mapping.** The U.S. BRAIN Initiative (launched 2014) and the EU Human Brain Project (2013‑2023) have generated massive datasets (e.g., high‑resolution connectomics) but have not yet produced a comprehensive theory of brain computation.  
* **Public perception of the singularity.** Popular media (e.g., *Westworld*, *Black Mirror*) continued to reference singularity concepts, but academic discourse grew more cautious, emphasizing “AI alignment” and “robustness” rather than inevitability.  
* **Business outcomes.** Companies that bet heavily on “singularity‑driven” hype (e.g., some early‑stage AI hardware startups) either pivoted to more pragmatic AI workloads or were acquired. No firm has achieved the exponential market dominance predicted by the original singularity narrative.

---

## 3. PREDICTIONS  

| Prediction (as implied in the article) | What actually happened (up to 2026) |
|---|---|
| **The brain’s complexity will be the primary brake on achieving a singularity.** | Brain‑mapping initiatives have produced petabytes of data, but a unifying computational theory remains elusive. Neuromorphic hardware has not displaced conventional AI chips. The brake persists. |
| **A new generation of micro‑chips within five years would enable a cure for cancer within ten.** | Chip performance (e.g., GPUs, TPUs) has indeed accelerated, but no cure for cancer has emerged. Treatments have improved, yet cancer remains a heterogeneous set of diseases. |
| **Singularity will be postponed; theoretical breakthroughs, not hardware scaling, will drive progress.** | The field has seen both hardware scaling (exascale GPUs) and theoretical advances (transformers, diffusion models). Progress is a blend, but no singularity event has occurred. The postponement prediction holds. |
| **Broad public and scientific optimism about near‑term singularity will wane.** | Academic conferences now feature “AI safety” and “interpretability” tracks; funding agencies request risk assessments. Public hype has shifted toward “AI as a tool” rather than an imminent existential shift. |

---

## 4. INTEREST  
**Rating: 7/10**  

The article is a useful historical snapshot of early‑2010s futurist debate, and its skepticism proved largely prescient regarding the timeline of a singularity and a rapid cancer cure. Its relevance endures for anyone studying the evolution of AI hype versus empirical progress, though the piece is not groundbreaking in its own right.


----
_model_params = {'model': 'openai/gpt-oss-120b:free', 'input': '20111017-singularity-postponed.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_